How should patients taking the discontinued diabetes drug troglitazone be managed?

Cleve Clin J Med. 2000 Jun;67(6):401-2, 455. doi: 10.3949/ccjm.67.6.401.
No abstract available

MeSH terms

  • Alanine Transaminase / blood
  • Chromans / adverse effects
  • Chromans / therapeutic use*
  • Diabetes Mellitus / drug therapy*
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Liver / drug effects
  • Pioglitazone
  • Rosiglitazone
  • Thiazoles / adverse effects
  • Thiazoles / therapeutic use*
  • Thiazolidinediones*
  • Troglitazone

Substances

  • Chromans
  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Rosiglitazone
  • Alanine Transaminase
  • Troglitazone
  • Pioglitazone